Cart
sales@molnova.com
Neoamygdalin
CAS No. 29883-16-7
Neoamygdalin( —— )
Catalog No. M34667 CAS No. 29883-16-7
Neoamygdalin is a bioactive chemical.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 297 | In Stock |
|
| 10MG | 471 | In Stock |
|
| 25MG | 753 | In Stock |
|
| 50MG | 995 | In Stock |
|
| 100MG | 1349 | In Stock |
|
| 200MG | 1823 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNeoamygdalin
-
NoteResearch use only, not for human use.
-
Brief DescriptionNeoamygdalin is a bioactive chemical.
-
DescriptionNeoamygdalin is a compound identified in the different processed bitter almonds. Neoamygdalin has the potential for the research of cough and asthma.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number29883-16-7
-
Formula Weight457.43
-
Molecular FormulaC20H27NO11
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (218.61 mM; Ultrasonic )
-
SMILESOC[C@H]1O[C@@H](OC[C@H]2O[C@@H](O[C@H](C#N)c3ccccc3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Xu S, et al. Identification and Analysis of Amygdalin, Neoamygdalin and Amygdalin Amide in Different Processed Bitter Almonds by HPLC-ESI-MS/MS and HPLC-DAD. Molecules. 2017;22(9):1425.?
molnova catalog
related products
-
ProTx III
Potent Nav1.7 blocker (IC50 = 2.5 nM). Also inhibits Nav1.1, Nav1.2, Nav1.3 and Nav1.6 in the nanomolar range. Exhibits no effects on Cav channels or nAChR at 5 μM. Demonstrates analgesic activity in vivo; antagonizes effects of scorpion-venom toxin OD1 at Nav1.7.
-
Aspartyl-alanyl-dike...
Ampion is a known immunomodulatory molecule from the N terminus of human albumin.
-
IDR-1
IDR-1 is an antimicrobial peptide that is active against Gram-positive and Gram-negative bacteria. IDR-1 counters infection by selective modulation of innate immunity without obvious toxicities. IDR-1 has anti-inflammatory and anti-infective properties, enhances the levels of monocyte chemokines, and attenuates pro-inflammatory cytokine release.
